Vivos Therapeutics Inc (NASDAQ: VVOS) announced two critical strategic agreements that will expand Vivos' current product line and are expected to create near-term
04.10.2023 - New Relationships Expected to Add Potentially Significant New Revenue Opportunities for Vivos as well as Airway-Focused Expertise and Potential Cost Savings for Vivos-trained ProvidersLITTLETON, Colo., Oct. 04, 2023 (GLOBE NEWSWIRE) - Vivos . Seite 1
Medical device and technology company Vivos Therapeutics, Inc. (VVOS) announced Wednesday two key strategic agreements with Ormco, a division of Envista Holdings Corp.
/PRNewswire/ Ormco Corporation today announces the launch of Ormco Digital Bonding (OBD). With this development, doctors can streamline daily workflow and.